SCAI Highlights Cardiac Dimensions Inc AMADEUS Study as an Important “Late Breaking” Clinical Trial

The Society of Cardiovascular Angiography and Interventions will highlight Cardiac Dimensions®, Inc.’s AMADEUS™ study during its 32nd annual scientific sessions held in Las Vegas, NV later this week.

Cardiac Dimensions®, Inc. Announces Key Personnel Changes

Two important additions to Cardiac Dimension®’s senior management team. Mr. Paul Cornelison recently joined the company as Vice President of Regulatory Affairs and Quality Assurance. In addition, Mr. Nawzer Mehta, Ph.D., has joined the company as Vice President of Clinical Affairs.

Most read

Latest

^